cetuximab (erbitux) Report issue

Biologics mAb Orphan Drug FDA Approved FDA Accelerated Approval FDA
Back

Drug Pricing Summary

AUS PBS

$226.0465 - $1130.2168

VA Big4

$450.0500 - $916.3000

VA FSS

$609.5200 - $1219.0400

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
cetuximab 100 mg / 20 mL (INJECTION) $226.0465 AUS PBS generic
  • Erbitux (1)
  • Merck Healthcare Pty Ltd
    cetuximab 2 mg / 1 mL (1 mL SOLUTION) $450.0500 VA Big4
  • ERBITUX (1)
  • Eli Lilly & Company
    cetuximab 2 mg / 1 mL (1 mL SOLUTION) $609.5200 VA FSS
  • ERBITUX (1)
  • Eli Lilly & Company
    cetuximab 2 mg / 1 mL (1 mL SOLUTION) $916.3000 VA Big4
  • ERBITUX (1)
  • Eli Lilly & Company
    cetuximab 2 mg / 1 mL (1 mL SOLUTION) $1219.0400 VA FSS
  • ERBITUX (1)
  • Eli Lilly & Company
    cetuximab 500 mg / 100 mL (INJECTION) $1130.2168 AUS PBS generic
  • Erbitux (1)
  • Merck Healthcare Pty Ltd

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue